GlassScriptPhysician profile
Ralph J Bourgeois
NPI 1285676163
$9,063.87
in general payments reported to CMS, 2019-2025
10 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.01 · 2020: $38.70 · 2021: $144 · 2022: $169 · 2023: $114 · 2024: $8,432 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Travel and Lodging: $1,353 · Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Travel and Lodging | $1,352.81 |
| Food and Beverage | $298.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,431.68 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $195.61 | 2022-2025 | Fasenra |
| Mylan Specialty L.P. | $136.22 | 2020-2021 | |
| Glaxosmithkline, LLC. | $77.50 | 2019-2023 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.42 | 2023 | Ofev |
| Tactile Systems Technology INC | $40.61 | 2022 | |
| Genentech USA, INC. | $39.95 | 2019 | |
| Medtronic, INC. | $37.54 | 2023 | Illumisite |
| Advanced Respiratory, INC | $25.23 | 2021 | |
| Ambu INC. | $23.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Bourgeois listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.